Wegovy kaufen

Buy Wegovy Weight Loss Injection

Buy Wegovy is a new weight loss treatment designed to reduce hunger. It is a once-weekly injection under the skin (subcutaneous injection).

You can buy Wegovy injection pens online pharmacy and doctor service. It is a prescription weight loss drug. After a short online consultation, your order will be forwarded to our doctors for review.

Once your order is approved, a prescription will be forwarded to our pharmacy team who can issue and ship your medication.

Wegovy contains the active ingredient semaglutide and is prescribed for adults with obesity. It was approved in the US in 2021 and has been available in the UK since September 2023.

If you find that Wegovy is not right for you, other weight loss treatments such as Orlistat are currently available through our online weight loss clinic. Wegovy kaufen

What is Wegovy?

Wegovy kaufen is a weight loss injection that, when combined with a reduced-calorie diet and increased exercise, can be an effective aid to weight loss. The weight loss medication contains the active ingredient semaglutide. Unlike other weight loss injections, Wegovy is injected once a week and can be used by adults with a body mass index (BMI) over 30. It can also be used by people with a BMI over 27 and weight-related conditions (such as high blood pressure or type 2 diabetes).

How is Wegovy taken?

The dose of Wegovy is increased every 4 weeks for 16 weeks. This means that patients take a dose of 0.25 mg once weekly for the first 4 weeks and gradually increase this until they reach the maintenance dose of 2.4 mg once weekly starting at week 17. This gradual increase is important because it minimizes the risk of side effects. If side effects do occur, they are usually seen during the dose escalation phase before they improve.

Is Wegovy an effective weight loss product?

Clinical trials have shown that treatment with Wegovy resulted in a statistically significant reduction in body weight after 68 weeks compared to placebo. One study showed that the body weight of people taking Wegovy changed by an average of 14.9%, compared to 2.4% in the placebo group.

The results also showed that after 68 weeks, 83.5% of patients had lost 5% or more of their body weight. In the placebo group, 31.1% of patients had lost 5% or more of their body weight. Another clinical study also showed a statistically significant reduction in body weight compared to placebo.

Due to the extremely positive study results, the National Institute for Health and Care Excellence (NICE) has recommended Wegovy for weight management in people with obesity.  Wegovy kaufen